Breast cancer conservation therapy in breast cancer patients with BRCA1/2 mutations
10.3760/cma.j.issn.1673-4203.2014.03.015
- VernacularTitle:保乳手术治疗BRCA1/2基因突变型乳腺癌的可行性
- Author:
Feng YANG
;
Jinfeng LI
- Publication Type:Journal Article
- Keywords:
Breast neoplasms;
Genes;
Surgical procedures,operative;
Familial breast cancer;
Breast cancer susceptibility gene 1/2;
Breast cancer conservation therapy
- From:
International Journal of Surgery
2014;41(3):192-196
- CountryChina
- Language:Chinese
-
Abstract:
As an important surgical approach,breast cancer conservation therapy is still controversial in breast cancer patients with BRCA1/2 mutations.Since the risk of unilateral multiple and contralateral incidences is high in the familial breast cancer patients with BRCA1/2 mutations,breast cancer conservation therapy is not recommended but mastectomy and/or immediate mamoplasty.However,if carriers have a strong desire of breast cancer conservation therapy,it is feasible if they are fully informed the risks that may exist.At that time,we should need bilateral oophorectomy,tamoxifen therapy,and more interventions for the prevention of contralateral breast incidences.
